A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Status:
RECRUITING
Trial end date:
2027-05-07
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.